News for 'Clinical Science'

Jayeshbhai Jordaar Review

Jayeshbhai Jordaar Review

Rediff.com13 May 2022

Essentially a message movie, Jayeshbhai Jordaar masks its horror in humour to play out like an on-the-run road trip, observes Sukanya Verma.

Too early to do away with face masks: Experts

Too early to do away with face masks: Experts

Rediff.com1 Apr 2022

The country saw a reduction in the number of swine flu cases due to masks and sanitation practices.

Have Kejriwal-Mann promised Punjab voters more than they can deliver?

Have Kejriwal-Mann promised Punjab voters more than they can deliver?

Rediff.com11 Mar 2022

Nothing exemplifies this Sikh khundak (revenge) better than the fact that all the tallest names in the state lost their election to novices fielded by AAP.

Govt launches web portal for COVID vaccine development

Govt launches web portal for COVID vaccine development

Rediff.com28 Sep 2020

The National Clinical Registry for COVID-19 will collect systematic data on clinical signs and symptoms, laboratory investigations, management protocols, the clinical course of COVID-19, disease spectrum and outcomes of patients.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Antiviral drug shows promise for treating COVID-19

Antiviral drug shows promise for treating COVID-19

Rediff.com30 Apr 2020

The White House described the development as "quite good news".

Next 2.5 months crucial in fight against Covid: Vardhan

Next 2.5 months crucial in fight against Covid: Vardhan

Rediff.com16 Oct 2020

He expressed hope that India will soon have indigenous production of vaccine against coronavirus.

China claims traditional medicines fight COVID-19

China claims traditional medicines fight COVID-19

Rediff.com18 Apr 2020

Studies in China claim that traditional Chinese medicines seem to be working effectively on patients with mild or moderate symptoms of coronavirus.

India's first Covid vaccine trial begins, 30-yr-old given 1st dose

India's first Covid vaccine trial begins, 30-yr-old given 1st dose

Rediff.com24 Jul 2020

In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

Rediff.com14 Apr 2021

The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

An Indian American in the White House?

An Indian American in the White House?

Rediff.com13 Mar 2023

What would an Indian American president of the US look like, sound like and act like, especially on issues and policies pertaining to his or her 'mother-land'?, asks N Sathiya Moorthy.

Govt drafts rules to help COVID-19 patients access new drugs

Govt drafts rules to help COVID-19 patients access new drugs

Rediff.com8 Jun 2020

According to a gazette notification of the draft rules published on June 5, a hospital or medical institution may import new drug for 'compassionate use for treatment of patients suffering from life threatening disease or disease causing serious permanent disability or disease requiring therapy for unmet medical need', which has not been permitted in the country, but under Phase-III clinical trial (human trial) in the country or abroad, by making an application to the Central Drug Regulator.

Record 28,472 COVID-19 patients recover in 24 hours

Record 28,472 COVID-19 patients recover in 24 hours

Rediff.com22 Jul 2020

India's COVID-19 recovery rate rose to 63.13 per cent on Wednesday with a record 28,472 patients recuperating from the disease in 24 hours, while the case fatality rate further dropped to 2.41 per cent, the Union health ministry said.

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

War brews between HUL, Sebamed over soap ads

War brews between HUL, Sebamed over soap ads

Rediff.com18 Jan 2021

Sebamed's campaign for its cleansing bar of the same name, released across print, television, digital and outdoor, has also named Santoor, a popular soap brand from Wipro Consumer Care.

Covid like a Test match, not ODI: AIIMS taskforce chief

Covid like a Test match, not ODI: AIIMS taskforce chief

Rediff.com20 May 2021

Chairperson of the COVID Task Force for All India Institute of Medical Sciences, Dr Naveet Wig on Thursday said that the COVID-19 crisis is 'a dynamic situation' and to prevent a third wave of the pandemic, there is a need to keep changing strategies.

India overtakes US to record highest number of COVID-19 recoveries

India overtakes US to record highest number of COVID-19 recoveries

Rediff.com19 Sep 2020

The country has reported the highest number of recoveries with 42,08,431 COVID-19 patients having recovered from the disease so far, pushing the national recovery rate to nearly 80 per cent, while the case fatality rate has further dropped to 1.61 per cent, the ministry said.

Govt seals deal for 30cr vaccines from Hyderabad firm

Govt seals deal for 30cr vaccines from Hyderabad firm

Rediff.com3 Jun 2021

The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials.

Who will get COVID-19 vaccine first? Vardhan explains

Who will get COVID-19 vaccine first? Vardhan explains

Rediff.com11 Oct 2020

'The prioritisation of groups for COVID-19 vaccine shall be based on two key considerations -- occupational hazard and risk of exposure to infection, and the risk of developing severe disease and increased mortality'

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Rediff.com20 Jul 2020

AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.

Hijab Case: Why Muslim Liberals Will Lose

Hijab Case: Why Muslim Liberals Will Lose

Rediff.com17 Oct 2022

The educated, respectable and established Muslims voices, that were on the modernising side on the Shah Bano issue, are fighting on the opposite side now, mostly because they worry about Narendra Modi, observes Shekhar Gupta.

Record 68,584 Covid patients recover in 24 hrs: Govt

Record 68,584 Covid patients recover in 24 hrs: Govt

Rediff.com3 Sep 2020

'India has registered the highest recoveries in a single day. 68,584 COVID-19 patients have recovered and been discharged in the last 24 hours. 'This has led to a surge in the total number of recovered patients which is nearly 30 lakh (2,970,492). 'With this, India's Recovery Rate amongst the COVID-19 patients has crossed 77 per cent (77.09 per cent), the govt said.

Criminal complaint against Ramdev for COVID-19 drug claim

Criminal complaint against Ramdev for COVID-19 drug claim

Rediff.com24 Jun 2020

The complaint seeking registration of a first information report on cheating, criminal conspiracy and other charges was filed in the court of Chief Judicial Magistrate Mukesh Kumar here on Tuesday by Tamanna Hashmi, who identifies himself as a social worker and is often in news for his numerous court complaints against politicians over various issues.

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

Rediff.com7 Jul 2021

The primary market is set for a bumper Rs 80,000-crore bonanza with 30 companies already filing IPO papers to raise Rs 55,000 crore, while around 10 more are lined up for this month itself, seeking to mop up another Rs 25,000 crore, say investment bankers. The market has been on a non-stop rally, hitting new records almost every week, on the back of an influx of investors -- a vast majority of them first-timers -- coupled with a flood of liquidity. Foreign funds alone had pumped in a record $35 billion into the market in FY21, while the trend has continued this fiscal as well. Domestic institutions led by LIC have also infused trillions of rupees, helping woo retail investors in troves -- the year saw over 20 million new investors coming to the market.

Not yet clear if Omicron more transmissible: WHO

Not yet clear if Omicron more transmissible: WHO

Rediff.com29 Nov 2021

The World Health Organisation has said it is 'not yet clear' whether the newly-detected coronavirus variant Omicron is more transmissible or causes more severe disease compared to other variants, including the highly-transmissible and globally prevalent Delta variant.

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Rediff.com11 Apr 2021

Remdesivir is considered a key anti-viral drug in the fight against Covid-19. In addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Reporting of COVID cases post vaccination rare: Vardhan

Reporting of COVID cases post vaccination rare: Vardhan

Rediff.com30 Mar 2021

Vardhan noted that COVID-19 infection among those vaccinated would be very mild and not progress to an advanced stage.

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Johnson & Johnson says its Covid shot neutralises Delta variant

Johnson & Johnson says its Covid shot neutralises Delta variant

Rediff.com2 Jul 2021

In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of rapidly emerging Beta and Zeta variants during the study period.

The teen who could revolutionise the war against heart attacks

The teen who could revolutionise the war against heart attacks

Rediff.com28 Dec 2017

He invented a skin patch that can detect a silent heart attack 6 hours before it happens!

Heart, BP patients likely to be infected with COVID-19 again: Study

Heart, BP patients likely to be infected with COVID-19 again: Study

Rediff.com24 Jun 2020

Researchers from Huazhong University of Science and Technology in China assessed data on 938 COVID-19 patients from the country's Wuhan Union Hospital. They obtained information about residual symptoms in these patients, and the results of follow up tests for viral genetic material in their body after they were discharged.

Mumbai student designs 'cool PPE kit' with ventilation for COVID warriors

Mumbai student designs 'cool PPE kit' with ventilation for COVID warriors

Rediff.com24 May 2021

This design serves two purposes -- first, keeps the health workers well-ventilated, while preventing bodily discomfort, and second, keeps them safe from various fungal infections.

What I learnt from fighting COVID-19

What I learnt from fighting COVID-19

Rediff.com24 Aug 2020

'The genetic thing is not in your control. The virulence is not known.' 'The only thing is if you can avoid it.' 'Once you get COVID-19, none of it is in your control.'

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

No one safe until all vaccinated for Covid: Johns Hopkins scientist

No one safe until all vaccinated for Covid: Johns Hopkins scientist

Rediff.com22 Apr 2022

Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster

Test for TB if cough persists: Govt's revised Covid guidelines

Test for TB if cough persists: Govt's revised Covid guidelines

Rediff.com18 Jan 2022

Anti-inflammatory or immunomodulatory therapy, such as steroids, can have the risk of secondary infection like invasive mucormycosis, when used too early, at higher dose or for longer than required, they highlighted.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

Rediff.com26 Oct 2021

The US will lift all restrictions for fully vaccinated international travellers, including from India, from November 8 but they will have to show proof of a negative coronavirus test before boarding a flight to the country, the White House has announced.